Header image

Industry Educational Session - Sponsored and promoted by Novartis: Putting Patients First in CML: Quality of Life, Optimised Therapy and Switching Strategies post-ELN Guidelines - Sponsored by Novartis

Tracks
-
Tuesday, April 21, 2026
12:30 PM - 1:15 PM
Room 4, Upper Level

Details

This promotional symposium is organised and funded by Novartis Pharmaceuticals UK, Ltd. intended for UK healthcare professionals only. Prescribing Information will be available at the meetings for all Novartis brands mentioned. Relevant Prescribing Information and Adverse Event Statement will be available at the meeting Join Dr Kate Rothwell, Kirsty Crozier, and Nick Duncan for a live, case‑based MDT lunchtime session for CML‑treating HCPs. This interactive discussion uses real‑world cases to showcase how the MDT work together to build a holistic picture of each patient’s needs—clinical, practical, and quality‑of‑life. Through an interactive session, we will focus on recognising TKI‑related QoL challenges that impact daily life, spotting triggers for treatment review, and navigating the complexities of patient management. We’ll highlight how nurses and pharmacists uncover day‑to‑day impact and support symptom management, how to strengthen patient education, and how to use clinical and patient‑reported data to support shared decision‑making. UK | FA-11598259 | March 2026


Speaker

Agenda Item Image
Dr. Kate Rothwell
Consultant
Leeds Teaching Hospitals NHS Trust

Speaker One

Consultant Haematology, CML and MDT lead at Calderdale and Huddersfield NHS Foundation Trust
Agenda Item Image
Mr Nick Duncan
Consultant Haematology Pharmacist
UHB NHS Foundation Trust

Speaker Two

Consultant Pharmacist at University Hospitals Birmingham NHS Foundation Trust
Agenda Item Image
Kirsty Crozier
NHS/University of Oxford

Speaker Three

Consultant Nurse at The Great Western Hospital and Lead Academic Research Nurse at University of Oxford
loading